Gentamicin, genetic variation and deafness in preterm children

First Page		Document Content
Pediatrics Preterm birth Ototoxicity Aminoglycoside Gentamicin Neonatal intensive care unit Neonatal sepsis Sensorineural hearing loss Colin Morley Medicine Health Aminoglycoside antibiotics		Gentamicin, genetic variation and deafness in preterm children Add to Reading List Source URL: www.ncbi.nlm.nih.gov Download Document from Source Website File Size: 128,34 KB Share Document on Facebook

	Original Research Article In vitro evaluation of antibacterial activity of verbascoside, lemon verbena extract and caffeine in combination with gentamicin against drugresistant Staphylococcus aureus and Escherichia coli DocID: 1v3Be - View Document
	Gentamicin X2 sulfate, EvoPure® Susceptibility and Minimum Inhibitory Concentration (MIC) Data Issue dateFor a complete list of references, please visit antibiotics.toku-e.com DocID: 1sNtI - View Document
	Garasol® (gentamicin) Injection: Leghorn Trials DocID: 1ssB4 - View Document
	Gentamicin A sulfate, EvoPure® Susceptibility and Minimum Inhibitory Concentration (MIC) Data Issue dateFor a complete list of references, please visit antibiotics.toku-e.com DocID: 1rMbj - View Document
	GENTAMICIN SULFATE MATERIAL SAFETY DATA SHEET RevisedSUBSTANCE IDENTITY Product Name DocID: 1rc0E - View Document